HS Code:
Polyethylenimine (CAS No. 9002-98-6), classified under HS subheading 3911.90.25, is a polymer with a wide range of applications, particularly as a component in the manufacturing of finished medical devices. It is often used for its adhesive properties, as a coating agent, or as a functional component in drug delivery systems and diagnostic tools due to its biocompatibility and chemical versatility. This category falls under the broader classification of 'other plastics in primary forms,' and its trade is driven by demand in the medical and pharmaceutical industries.
Total Trade Volume
USD 250 million
Data from 2022
Source
United Nations Comtrade Database & International Trade Centre (ITC)
Average Rate
5.2%
Highest Rate
10% (applied by certain developing countries to protect domestic industries)
Lowest Rate
0% (under free trade agreements like EU-USMCA or within ASEAN)
Growing demand for medical devices
Increased trade volume due to rising global healthcare needs and advancements in medical technology requiring specialized polymers like polyethylenimine.
2021-2023
Shift towards sustainable materials
Pressure on manufacturers to develop eco-friendly production methods for polyethylenimine, influencing trade patterns as countries with stricter environmental laws may impose higher costs or restrictions.
2022-2023
Regional production hubs in Asia
China and South Korea are emerging as key exporters due to lower production costs and proximity to medical device manufacturing centers, reshaping global supply chains.
2020-2023
The European Union introduced stricter guidelines under the Medical Device Regulation (MDR) for components like polyethylenimine, requiring enhanced documentation and biocompatibility testing.
May 2023
Increased compliance costs for exporters to the EU, potentially reducing trade volumes from non-compliant suppliers.
A new phase of trade negotiations between the US and China included reduced tariffs on certain chemical and polymer products, including those under HS 3911.90.25.
January 2023
Boosted exports from China to the US, strengthening China's position in the market.
Several companies in Germany and Japan announced advancements in polyethylenimine formulations tailored for next-generation medical devices, such as improved drug delivery systems.
September 2022
Likely to drive demand and trade volume as new applications emerge in the medical sector.